News Feed.

Read our latest articles and posts on medical and our company.

Meet Our Team

KYBORA is moving to a new office in Princeton, NJ

We are pleased to announce that KYBORA is moving to a new office location on Witherspoon Street in Princeton, New Jersey.  The new office is ideally located within walking distance of…
READ MORE

KYBORA is moving to a new office in Princeton, NJ

We are pleased to announce that KYBORA is moving to a new office location on Witherspoon Street in Princeton, New…
READ MORE

KYBORA GmbH is pleased to announce the appointments of SASCHA BUCHER, ERIC DOULAT, and STEPHEN STEAD to its Board of Directors

BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght, founder and Chief Executive Officer of KYBORA Group and Chairman of the Board…
READ MORE

KYBORA Appoints Jean CHATELLIER as Executive Vice President of KYBORA and, Managing Director and Member of the Board of Directors of its European Affiliate, KYBORA GmbH

PRINCETON, N.J., AND BASEL, SWITZERLAND (PRWEB) MARCH 17, 2021 Alan Vanderborght said, “I am thrilled to have Jean join our team.…
READ MORE

KYBORA Opens its First Fully Owned Affiliate, KYBORA GmbH in Basel, Switzerland

PRINCETON, N.J. (PRWEB) MARCH 16, 2021 Alan Vanderborght, Founder and CEO of KYBORA, said: “The opening of KYBORA GmbH is the…
READ MORE

KYBORA is attending Bio Partnering at JPM

KYBORA is attending Bio Partnering at JPM. We look forward to connecting with you there and show you how to…
READ MORE
Russian Federation Pharma

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular…
READ MORE

KYBORA Sponsors the Bio Latin America Conference Again

KYBORA is happy to announce that it will sponsor the Bio Latin America Conference again this year. https://biolatinamerica.com/sponsors/ Taking place…
READ MORE

Is China High Enough on Your Priority List?

“If you are a U.S. company that does not yet have a China strategy…you need to get moving or risk…
READ MORE

KYBORA successfully helps Stada license Xlucane to Bausch Health

KYBORA is pleased to announce that it has successfully helped its client STADA Arzneimittel AG license Xlucane – a Ranibizumab…
READ MORE

KYBORA Welcomes Anton Leshchenko to the Team

KYBORA is pleased to announce that Anton Leshchenko has joined its team as Managing Director, responsible for expanding KYBORA’s operations…
READ MORE

KYBORA Welcomes Rainer Wulf to the Team

KYBORA is pleased to announce that Rainer Wulf has joined Kybora as a new member of the advisory board. Rainer…
READ MORE

TYPE & ENTER: